Phibro Animal Health reported $220.42M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Align Technology ALGN:US $ 775.14M 35.07M
Ani Pharmaceuticals ANIP:US $ 83.67M 980K
Aurora Cannabis Inc ACB:CN 1.05B 921.9M
Bristol Myers Squibb BMY:US $ 9.1B 247M
Canopy Growth Corp WEED:CN C$ 641.41M 350.48M
Corcept Therapeutics CORT:US $ 66.92M 4.76M
Depomed DEPO:US $ 24.98M 368K
Eli Lilly And LLY:US $ 5405.7M 677M
Endo International Ordinary Shares ENDP:US $ 583.27M 618.52M
Henry Schein HSIC:US $ 2935M 194.96M
Idexx Laboratories IDXX:US $ 588.2M 13.69M
JAZZ PHA JAZZ:US $ 726.17M 121.18M
Knight Therapeutics Inc GUD:CN C$ 63.85M 8.85M
Lannett LCI:US $ 100.44M 54.15M
Merk MRK:US $ 10332M 386M
Nektar Therapeutics NKTR:US $ 141.38M 3.46M
Pacira Pharmaceuticals PCRX:US $ 140.6M 14.38M
Phibro Animal Health PAHC:US $ 220.42M 10.01M
Prestige Brands PBH:US $ 189.51M 2.36M
Supernus Pharmaceuticals SUPN:US $ 150.54M 2.41M
Teva Pharmaceutical Industries TEVA:US 4.37B 352M
Zoetis ZTS:US $ 1.26B 202M